 ROCKVILLE, Md., May 09, 2022 GLOBE NEWSWIRE -- Synthetic Biologics, Inc. NYSE American: SYN, a diversified clinical-stage company developing therapeutics designed to treat diseases in areas of high unmet need, today announced that it plans to host a conference call on Monday, May 16, 2022, at 8:30 a.m. ET to discuss its financial results for the quarter ended March 31, 2022 and provide a corporate update. 